- Report
- January 2024
- 200 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- January 2024
- 251 Pages
Global
From €5219EUR$5,561USD£4,350GBP
- Report
- September 2023
- 168 Pages
Global
From €5342EUR$5,500USD£4,608GBP
- Report
- October 2023
- 110 Pages
Global
From €5779EUR$5,950USD£4,985GBP
- Report
- January 2024
- 200 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- January 2024
- 200 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- March 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- February 2024
- 175 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- February 2024
- 200 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- January 2024
- 200 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- January 2024
- 200 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- December 2023
- 200 Pages
Global
From €4856EUR$5,000USD£4,189GBP
- Report
- August 2023
- 154 Pages
Global
From €2428EUR$2,500USD£2,095GBP
- Report
- February 2024
- 110 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- February 2024
- 115 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- February 2024
- 114 Pages
Global
From €4614EUR$4,750USD£3,980GBP
- Report
- January 2024
- 200 Pages
Global
From €4031EUR$4,150USD£3,477GBP
- Report
- August 2023
- 112 Pages
Global
From €3885EUR$4,000USD£3,351GBP
- Report
- September 2020
- 294 Pages
Global
From €4758EUR$4,899USD£4,105GBP
- Report
- September 2018
- 514 Pages
Global
From €3398EUR$3,499USD£2,932GBP
The Neurotech market is a subset of the Neurology Devices industry, focusing on the development and commercialization of products and services related to the diagnosis, treatment, and management of neurological disorders. Neurotech products range from medical devices such as brain-computer interfaces, deep brain stimulation systems, and neuroprosthetics, to software and digital health solutions such as brain-computer interfaces, virtual reality, and artificial intelligence. Neurotech companies are also developing novel treatments for neurological disorders, such as gene therapy, stem cell therapy, and gene editing.
The Neurotech market is driven by advances in technology, increasing prevalence of neurological disorders, and growing demand for personalized treatments. Neurotech companies are also leveraging the power of data to develop more effective treatments and improve patient outcomes.
Notable companies in the Neurotech market include NeuroPace, NeuroMetrix, BrainScope, NeuroSigma, NeuroVista, and NeuroSens. Show Less Read more